The American pharmaceutical company Bristol-Myers Squibb announced that it will buy biotech MyoKardia for $ 13.1 billion. Quotes of the MyoKardia at the previous trading increased by 59%. Bristol will pay $ 225 for each share of the MyoKardia, corresponding to 61% premium to the value of the company’s securities at the close of trading […]